Cargando…

Survival Analysis of Gastric Cancer Patients with Incomplete Data

PURPOSE: Survival analysis of gastric cancer patients requires knowledge about factors that affect survival time. This paper attempted to analyze the survival of patients with incomplete registered data by using imputation methods. MATERIALS AND METHODS: Three missing data imputation methods, includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghimbeigi, Abbas, Tapak, Lily, Roshanaei, Ghodaratolla, Mahjub, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286905/
https://www.ncbi.nlm.nih.gov/pubmed/25580358
http://dx.doi.org/10.5230/jgc.2014.14.4.259
_version_ 1782351725818019840
author Moghimbeigi, Abbas
Tapak, Lily
Roshanaei, Ghodaratolla
Mahjub, Hossein
author_facet Moghimbeigi, Abbas
Tapak, Lily
Roshanaei, Ghodaratolla
Mahjub, Hossein
author_sort Moghimbeigi, Abbas
collection PubMed
description PURPOSE: Survival analysis of gastric cancer patients requires knowledge about factors that affect survival time. This paper attempted to analyze the survival of patients with incomplete registered data by using imputation methods. MATERIALS AND METHODS: Three missing data imputation methods, including regression, expectation maximization algorithm, and multiple imputation (MI) using Monte Carlo Markov Chain methods, were applied to the data of cancer patients referred to the cancer institute at Imam Khomeini Hospital in Tehran in 2003 to 2008. The data included demographic variables, survival times, and censored variable of 471 patients with gastric cancer. After using imputation methods to account for missing covariate data, the data were analyzed using a Cox regression model and the results were compared. RESULTS: The mean patient survival time after diagnosis was 49.1±4.4 months. In the complete case analysis, which used information from 100 of the 471 patients, very wide and uninformative confidence intervals were obtained for the chemotherapy and surgery hazard ratios (HRs). However, after imputation, the maximum confidence interval widths for the chemotherapy and surgery HRs were 8.470 and 0.806, respectively. The minimum width corresponded with MI. Furthermore, the minimum Bayesian and Akaike information criteria values correlated with MI (-821.236 and -827.866, respectively). CONCLUSIONS: Missing value imputation increased the estimate precision and accuracy. In addition, MI yielded better results when compared with the expectation maximization algorithm and regression simple imputation methods.
format Online
Article
Text
id pubmed-4286905
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Gastric Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-42869052015-01-11 Survival Analysis of Gastric Cancer Patients with Incomplete Data Moghimbeigi, Abbas Tapak, Lily Roshanaei, Ghodaratolla Mahjub, Hossein J Gastric Cancer Original Article PURPOSE: Survival analysis of gastric cancer patients requires knowledge about factors that affect survival time. This paper attempted to analyze the survival of patients with incomplete registered data by using imputation methods. MATERIALS AND METHODS: Three missing data imputation methods, including regression, expectation maximization algorithm, and multiple imputation (MI) using Monte Carlo Markov Chain methods, were applied to the data of cancer patients referred to the cancer institute at Imam Khomeini Hospital in Tehran in 2003 to 2008. The data included demographic variables, survival times, and censored variable of 471 patients with gastric cancer. After using imputation methods to account for missing covariate data, the data were analyzed using a Cox regression model and the results were compared. RESULTS: The mean patient survival time after diagnosis was 49.1±4.4 months. In the complete case analysis, which used information from 100 of the 471 patients, very wide and uninformative confidence intervals were obtained for the chemotherapy and surgery hazard ratios (HRs). However, after imputation, the maximum confidence interval widths for the chemotherapy and surgery HRs were 8.470 and 0.806, respectively. The minimum width corresponded with MI. Furthermore, the minimum Bayesian and Akaike information criteria values correlated with MI (-821.236 and -827.866, respectively). CONCLUSIONS: Missing value imputation increased the estimate precision and accuracy. In addition, MI yielded better results when compared with the expectation maximization algorithm and regression simple imputation methods. The Korean Gastric Cancer Association 2014-12 2014-12-26 /pmc/articles/PMC4286905/ /pubmed/25580358 http://dx.doi.org/10.5230/jgc.2014.14.4.259 Text en Copyright © 2014 by The Korean Gastric Cancer Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Moghimbeigi, Abbas
Tapak, Lily
Roshanaei, Ghodaratolla
Mahjub, Hossein
Survival Analysis of Gastric Cancer Patients with Incomplete Data
title Survival Analysis of Gastric Cancer Patients with Incomplete Data
title_full Survival Analysis of Gastric Cancer Patients with Incomplete Data
title_fullStr Survival Analysis of Gastric Cancer Patients with Incomplete Data
title_full_unstemmed Survival Analysis of Gastric Cancer Patients with Incomplete Data
title_short Survival Analysis of Gastric Cancer Patients with Incomplete Data
title_sort survival analysis of gastric cancer patients with incomplete data
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286905/
https://www.ncbi.nlm.nih.gov/pubmed/25580358
http://dx.doi.org/10.5230/jgc.2014.14.4.259
work_keys_str_mv AT moghimbeigiabbas survivalanalysisofgastriccancerpatientswithincompletedata
AT tapaklily survivalanalysisofgastriccancerpatientswithincompletedata
AT roshanaeighodaratolla survivalanalysisofgastriccancerpatientswithincompletedata
AT mahjubhossein survivalanalysisofgastriccancerpatientswithincompletedata